A case of adult-onset type II citrullinemia with repeated nonconvulsive status epilepticus

Clinical Neurology

Volumn 49, Issue 9, 2009, Pages 571-575

  Funabe, Sayaka ^a   Tanaka, Ryota ^a   Urabe, Takao ^a   Kawasaki, Seiji ^a   Kobayashi, Keiko ^b   Hattori, Nobutaka ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Adult onset type II citrullinemia; Consciousness disturbance; Nonconvulsive status epilepticus

Indexed keywords

AMMONIA; BENZODIAZEPINE; DIAZEPAM;

ABNORMAL BEHAVIOR; ADULT; ADULT ONSET TYPE II CITRULLINEMIA; AMMONIA BLOOD LEVEL; ARTICLE; CASE REPORT; CITRULLINEMIA; CONFUSION; DISORIENTATION; EEG ABNORMALITY; EPILEPTIC STATE; FEMALE; HUMAN; HYPERAMMONEMIA; LIVER TRANSPLANTATION; NONCONVULSIVE EPILEPTIC STATE; PERSONALITY DISORDER; UNCONSCIOUSNESS;

EID: 71949098952     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: 10.5692/clinicalneurol.49.571     Document Type: Article

References (17)

1. Walker M, Cross H, Smith S, et al: Nonconvulsive status epilepticus. Epilepsy research foundation workshop reports. Epileptic Disord 2005; 7: 253-296
2. Kobayashi K, Sinasac D, Iijima M, et al: The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein. Nature Genet 1999; 22: 159-163 (Pubitemid 29264809)
3. Kobayashi K, Horiuti M, Saheki T: Pancreatic secretory trypsin inhibitor as a diagnostic marker for adult onset type II citrullinemia. Hepatology 1997; 25: 1160-1165 (Pubitemid 27199944)
4. Imamura Y, Kobayashi K, Shibatou T, et al: Effectiveness of carbohydrate-restricted diet and arginine granules therapy for adult-onset type II citrullinemia: a case report of siblings showing homozygous SLC25A13 mutation with and without the disease. Hepatol Res 2003; 26: 68-72 (Pubitemid 36939934)
5. Masahide Y, Takei Y, Kobayashi K, et al: Risk of worsened encephalopathy after intravenous glycerol therapy in patients with adult-onset type II citrullinemia (CTLN2). Internal Medicine 2005; 44: 188-195 (Pubitemid 40575896)
6. Yamaguchi N, Kobayashi K, Yasuda T, et al: Screening of SLC25A13 mutations in early and late onset patients with citrin deficiency and in the Japanese population: identification of two novel mutations and establishment of multiple DNA diagnosis method for nine mutations. Hum Mutat 2002; 19: 122-130 (Pubitemid 34121803)
7. Meierkord H, Holtkamp M: Non-convuisive status epilepticus in adults: clinical forms and treatment. Lancet Neurol 2007; 6: 329-339 (Pubitemid 46367947)
8. Bearden S, Eisenschenk S, Uthman B, et al: Diagnosis of nonconvulsive status epilepticus (NCSE) in Adults with altered mental status: clinico-electroencephalographic considerations. Am J End Technol 2008; 48: 11-37 (Pubitemid 352006494)
9. Velioglu SK, Gazioglu S: Non-convulsive status epilepticus secondary to valproic acid induced hyperammonemic encephalopathy. Acta Neuro Scand 2007; 116: 128-132
10. Wasterline CJ, Fujikawa DG, Penix L, et al: Pathophysiological mechanisms of brain damage from status epilepticus. Epilepsia 1993; 34: 37-53 (Pubitemid 23107999)
11. Kobayashi K, Iijima M, Yasuda T, et al: Type II citrullinemia (citrin deficiency): a mysterious disease caused by a defect of calcium-binding mitochondrial carrier protein. In Calcium: The Molecular Basis of Calcium Action in Biology and Medicine, ed by Pochet R, Donato R, Haiech J, et al, Kluwer Academic Publishers, Dordrecht, 2000, pp 565-587
12. Ikeda S, Yazaki M, Ikegami T, et al: Type II (adult onset) citrullinemiae: clinical pictures and the therapeutic effect of liver transplantation. J Neurol Neurosurg Psychiatry 2001; 71: 663-670 (Pubitemid 33010583)